Abstract
Infection is a leading cause of death in patients with multiple myeloma. It occurs most often during the first 2 months after diagnosis. The spectrum of infections has changed: Streptococcus pneumoniae is no longer the most common organism isolated, and gram-negative infections are seen more often. Immunoprophylaxis with monthly intravenous immune globulin (IVIG) may reduce the risk of serious and recurrent infections.
| Original language | English |
|---|---|
| Pages (from-to) | 353-362 |
| Number of pages | 10 |
| Journal | Infections in Medicine |
| Volume | 12 |
| Issue number | 8 |
| State | Published - 1995 |
| Externally published | Yes |
Keywords
- cancer
- immune globulin, intravenous (IVIG)
- myeloma